| |
|
Complex supply chains demand a holistic approach to protect patients
The USP <1083> standard, currently in draft form, is an effort to provide recommendations for end-to-end supply chain integrity
|
|
In the evolving world of pharma compliance, The PDMA Sharing Conference provides answers
|
|
The clear and present danger of counterfeit drugs
Prospects for international policing of counterfeit drugs is dim.
|
|
Packaging, serialization and medication adherence: the coming connection
Modernized packaging technologies can change the drug-distribution dynamic - and improve overall healthcare.
|
|
Supply chains for a patient-centric world
Tomorrow's healthcare market, driven by consumer choice and outcomes-driven economics, will create new supply chain models
|
|
FTC Approves Express Scripts/Medco Merger: Excerpts
Merger is not expected to affect specialty-distribution agreements negatively
|
|
Jobs and biopharma
Ten-year BLS projection sees a healthy industry ahead
|
|
Drug Wholesalers and the Generic Price War
While the drug wholesaling industry appears reasonably healthy right now, the ongoing generic drug price war among retail pharmacies will create the risk of reduced wholesaler profitability . . .
|
|
Biosimilars take a big step toward the marketplace
FDA's draft documents on biosimilar regulation move the prospect one step closer
|
|
Supply chain issues for 2012
Tompkins International's annual preview of key pharma supply chain issues
|
|
|
|
|
